Cash flow CureVac N.V.

Equities

CVAC

NL0015436031

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 04:00:00 2025-06-13 pm EDT			5-day change	1st Jan Change
5.570 ^USD	-0.54%		+26.30%	+63.34%

Jun. 13	Jefferies Downgrades CureVac to Hold From Buy, $5 Price Target	MT
Jun. 13	CUREVAC : Downgraded to Neutral by Jefferies	ZD

7b3e09f25fb83b27f16b25c052cf4ce.vgY_X53yaDCdbQ0LwJGi3dO4-k6jV-giJQAf0CpbwDo.3zEPGeylJnjrJk5ClNryj6Xxsh_iO51rYTZV6H4il1fsdF4-1IUbcvcGYg

Published financial data: CUREVAC N.V.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	48.87M	103M	67.42M	53.76M	535M
Total Revenues	48.87M	103M	67.42M	53.76M	535M
Cost of Goods Sold, Total	14.12M	238M	159M	116M	106M
Gross Profit	34.75M	-135M	-91.55M	-62.45M	430M
Selling General & Admin Expenses, Total	54.34M	102M	107M	95.74M	74.34M
R&D Expenses	114M	816M	62.55M	116M	153M
Other Operating Expenses	154K	-98K	-34.83M	-2.17M	-7.6M
Other Operating Expenses, Total	168M	918M	135M	209M	220M
Operating Income	-134M	-1.05B	-226M	-272M	210M
Interest Expense, Total	-22.1M	-10.34M	-3.71M	-	-
Interest And Investment Income	2.07M	10.1M	4.01M	15.41M	12.36M
Net Interest Expenses	-20.03M	-235K	302K	15.41M	12.36M
Currency Exchange Gains (Loss)	-	-	-	-1.21M	842K
Other Non Operating Income (Expenses)	-	-	-	37K	0
EBT, Excl. Unusual Items	-154M	-1.05B	-226M	-258M	223M
Restructuring Charges	-	-	-	-	-32.1M
Gain (Loss) On Sale Of Assets	-	-	785K	1.2M	-
Asset Writedown	-	-	-24.95M	-8.08M	-
Insurance Settlements	-	-	610K	860K	-
Other Unusual Items	23.74M	641M	440K	3.57M	-
EBT, Incl. Unusual Items	-130M	-412M	-249M	-260M	191M
Income Tax Expense	-726K	-782K	-126K	198K	28.7M
Earnings From Continuing Operations	-129M	-412M	-249M	-260M	162M
Net Income to Company	-129M	-412M	-249M	-260M	162M
Net Income - (IS)	-129M	-412M	-249M	-260M	162M
Net Income to Common Incl Extra Items	-129M	-412M	-249M	-260M	162M
Net Income to Common Excl. Extra Items	-129M	-412M	-249M	-260M	162M
Per Share Items
Net EPS - Basic	-0.98	-2.21	-1.32	-1.18	0.72
Basic EPS - Continuing Operations	-0.98	-2.21	-1.32	-1.18	0.72
Basic Weighted Average Shares Outstanding	132M	186M	189M	221M	224M
Net EPS - Diluted	-0.98	-2.21	-1.32	-1.18	0.72
Diluted EPS - Continuing Operations	-0.98	-2.21	-1.32	-1.18	0.72
Diluted Weighted Average Shares Outstanding	132M	186M	189M	221M	224M
Normalized Basic EPS	-0.73	-3.54	-0.75	-0.73	0.62
Normalized Diluted EPS	-0.73	-3.54	-0.75	-0.73	0.62
Supplemental Items
EBITDA	-128M	-1.04B	-210M	-255M	223M
EBITA	-132M	-1.05B	-223M	-268M	212M
EBIT	-134M	-1.05B	-226M	-272M	210M
EBITDAR	-128M	-1.04B	-209M	-255M	223M
Effective Tax Rate - (Ratio)	0.56	0.19	0.05	-0.08	15.03
Total Current Taxes	403K	1.03M	-	118K	19.11M
Total Deferred Taxes	-1.13M	-1.82M	-	80K	9.59M
Normalized Net Income	-95.99M	-658M	-141M	-161M	139M
Interest Capitalized	1.99M	2.93M	2.29M	2.38M	2.31M
Interest on Long-Term Debt	3.65M	4.66M	4.51M	2.38M	2.31M
Supplemental Operating Expense Items
Selling and Marketing Expenses	733K	1.74M	2.82M	3.91M	4.45M
General and Administrative Expenses	53.52M	100M	104M	91.7M	69.65M
Research And Development Expense From Footnotes	114M	816M	62.55M	116M	153M
Net Rental Expense, Total	78K	158K	142K	125K	237K
Imputed Operating Lease Interest Expense	224K	399K	192K	56.61K	109K
Imputed Operating Lease Depreciation	-146K	-241K	-50K	68.39K	128K
Stock-Based Comp., COGS (Total)	-	-	-	340K	295K
Stock-Based Comp., R&D Exp. (Total)	1.84M	958K	885K	1.7M	1.79M
Stock-Based Comp., S&M Exp. (Total)	4.95M	295K	184K	275K	98K
Stock-Based Comp., G&A Exp. (Total)	5.69M	13.12M	7.64M	4.73M	1.39M
Stock-Based Comp., Other (Total)	713K	583K	479K	652K	553K
Total Stock-Based Compensation	13.19M	14.96M	9.18M	7.7M	4.12M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	1.32B	811M	496M	402M	482M
Short Term Investments	2.62M	-	-	-	-
Total Cash And Short Term Investments	1.33B	811M	496M	402M	482M
Accounts Receivable, Total	1.82M	18.5M	9M	17.08M	16.84M
Other Receivables	8.24M	37.95M	32.99M	23.15M	16.04M
Total Receivables	10.06M	56.45M	41.99M	40.24M	32.88M
Inventory	14.53M	56.16M	23.99M	24.8M	541K
Prepaid Expenses	40.05M	5.72M	9.85M	6.54M	791K
Other Current Assets, Total	-	10.22M	12.4M	4.36M	10.45M
Total Current Assets	1.39B	940M	584M	478M	526M
Gross Property Plant And Equipment	125M	247M	271M	316M	323M
Accumulated Depreciation	-24.09M	-47.02M	-29.57M	-37.42M	-78.53M
Net Property Plant And Equipment	101M	200M	242M	279M	245M
Goodwill	-	-	12.46M	12.46M	12.46M
Other Intangibles, Total	13.46M	12.27M	19.3M	15.88M	12.69M
Deferred Tax Assets Long-Term	445K	2.86M	1.3M	1.19M	5.09M
Deferred Charges Long-Term	1.03M	515K	302K	-	-
Other Long-Term Assets, Total	5.98M	2.18M	1.38M	1.7M	1.51M
Total Assets	1.51B	1.16B	860M	788M	803M
Liabilities
Accounts Payable, Total	17.62M	122M	68.24M	-	17.27M
Accrued Expenses, Total	19.19M	9.36M	10.05M	59.07M	11.13M
Current Portion of Leases	3.23M	3.47M	4.98M	5M	5.32M
Current Income Taxes Payable	392K	739K	610K	654K	18.25M
Unearned Revenue Current, Total	194M	58.92M	36.78M	46.32M	-
Other Current Liabilities	13.14M	163M	35.56M	75.35M	20.38M
Total Current Liabilities	248M	358M	156M	186M	72.35M
Long-Term Debt	25.19M	-	-	-	-
Long-Term Leases	26.85M	25.42M	37.11M	36.82M	33.64M
Unearned Revenue Non Current	500M	86.34M	72.55M	48.1M	-
Deferred Tax Liability Non Current	-	-	-	-	227K
Other Non Current Liabilities	284K	264K	61.34M	-	-
Total Liabilities	800M	470M	327M	271M	106M
Common Stock, Total	21.66M	22.45M	23.4M	26.88M	26.92M
Retained Earnings	-645M	-1.06B	-1.31B	-1.57B	-1.4B
Treasury Stock	-	-5.82M	-1.48M	-	-
Comprehensive Income and Other	1.33B	1.73B	1.82B	2.06B	2.07B
Total Common Equity	711M	688M	533M	517M	697M
Total Equity	711M	688M	533M	517M	697M
Total Liabilities And Equity	1.51B	1.16B	860M	788M	803M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	180M	187M	195M	224M	225M
ECS Total Common Shares Outstanding	180M	187M	195M	224M	224M
Book Value / Share	3.94	3.68	2.74	2.31	3.11
Tangible Book Value	698M	676M	501M	489M	671M
Tangible Book Value Per Share	3.87	3.61	2.57	2.18	2.99
Total Debt	55.28M	28.89M	42.09M	41.82M	38.96M
Net Debt	-1.27B	-783M	-454M	-361M	-443M
Debt Equivalent Oper. Leases	624K	1.26M	1.14M	1M	1.9M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	13.79M	56.16M	23.99M	-	-
Inventories - Finished Goods, Total	741K	-	-	-	-
Inventories - Others	-	-	-	-	-
Buildings, Total	19.95M	27.27M	26.47M	27.54M	28.2M
Machinery, Total	31.63M	63.47M	62.58M	67.68M	71.64M
Full Time Employees	455	764	904	999	825
Part Time Employees	99	120	145	173	158

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-129M	-412M	-249M	-260M	162M
Depreciation & Amortization - CF	7.89M	10.97M	18.45M	18.33M	15.36M
Amortization of Goodwill and Intangible Assets - (CF)	1.66M	2.54M	3.35M	4.24M	2.55M
Depreciation & Amortization, Total	9.54M	13.51M	21.8M	22.57M	17.91M
Amortization of Deferred Charges, Total - (CF)	1.13M	2.16M	1.94M	820K	895K
(Gain) Loss From Sale Of Asset	5.92M	587K	31.04M	10.19M	646K
Asset Writedown & Restructuring Costs	-	22.81M	6.59M	2.47M	35.3M
Stock-Based Compensation (CF)	14.24M	14.96M	9.18M	7.7M	4.12M
Other Operating Activities, Total	10.52M	-399M	17.85M	16.83M	44.75M
Change In Accounts Receivable	15.33M	-16.68M	9.5M	-8.08M	11.47M
Change In Inventories	-8.33M	-227M	-47.85M	-47.94M	590K
Change In Accounts Payable	620M	179M	-96.19M	-29.98M	-141M
Change in Unearned Revenues	31.6M	93.53M	-	-	-
Change In Deferred Taxes	-1.1M	-1.58M	4K	-115K	-
Change in Other Net Operating Assets	-47.63M	-3.14M	8.97M	17.83M	-35.44M
Cash from Operations	522M	-733M	-286M	-268M	102M
Capital Expenditure	-36.33M	-124M	-88.02M	-52.32M	-14.32M
Cash Acquisitions	-	-	-277K	-	-
Sale (Purchase) of Intangible assets	-11.02M	-3.68M	-5.2M	-2.88M	-4.13M
Investment in Marketable and Equity Securities, Total	-1.16M	-	-	-	-
Other Investing Activities, Total	3.24M	-	-	-	-
Cash from Investing	-45.27M	-128M	-93.5M	-55.2M	-18.44M
Long-Term Debt Issued, Total	49.86M	-	-	-	-
Total Debt Issued	49.86M	-	-	-	-
Long-Term Debt Repaid, Total	-97.74M	-28.18M	-4.22M	-5.19M	-5.11M
Total Debt Repaid	-97.74M	-28.18M	-4.22M	-5.19M	-5.11M
Issuance of Common Stock	868M	407M	67.39M	236M	-
Repurchase of Common Stock	-	-34.1M	-	-	-
Cash from Financing	820M	345M	63.17M	231M	-5.11M
Foreign Exchange Rate Adjustments	-5.05M	4.94M	836K	-1.15M	1M
Net Change in Cash	1.29B	-511M	-316M	-93.34M	79.3M
Supplemental Items
Cash Interest Paid	-	9.78M	4.61M	2.38M	2.32M
Cash Income Tax Paid (Refund)	93K	502K	128K	3.89M	3.15M
Levered Free Cash Flow	57.92M	-713M	-367M	-152M	52.51M
Unlevered Free Cash Flow	71.73M	-707M	-364M	-152M	52.51M
Change In Net Working Capital	-179M	-48.58M	163M	-42.44M	83.09M
Net Debt Issued / Repaid	-47.88M	-28.18M	-4.22M	-5.19M	-5.11M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-10.17	-49.31	-14.02	-20.6	16.48
Return on Total Capital	-20.79	-88.71	-21.89	-29.95	20.26
Return On Equity %	-38.63	-58.82	-40.77	-49.55	26.73
Return on Common Equity	-38.63	-58.82	-40.77	-49.55	26.73
Margin Analysis
Gross Profit Margin %	71.1	-131.16	-135.79	-116.17	80.26
SG&A Margin	111.18	99.3	158.81	178.09	13.89
EBITDA Margin %	-261.36	-1.01K	-310.89	-474.25	41.59
EBITA Margin %	-269.88	-1.02K	-330.75	-497.61	39.68
EBIT Margin %	-273.27	-1.02K	-335.72	-505.49	39.2
Income From Continuing Operations Margin %	-264.21	-399.76	-369.37	-483.96	30.3
Net Income Margin %	-264.21	-399.76	-369.37	-483.96	30.3
Net Avail. For Common Margin %	-264.21	-399.76	-369.37	-483.96	30.3
Normalized Net Income Margin	-196.42	-639.26	-209.55	-299.38	26.04
Levered Free Cash Flow Margin	118.52	-692.66	-544.01	-281.85	9.81
Unlevered Free Cash Flow Margin	146.78	-686.39	-540.58	-281.85	9.81
Asset Turnover
Asset Turnover	0.06	0.08	0.07	0.07	0.67
Fixed Assets Turnover	0.6	0.68	0.31	0.21	2.05
Receivables Turnover (Average Receivables)	5.15	10.13	4.9	4.12	31.55
Inventory Turnover (Average Inventory)	1.36	6.74	3.97	4.76	8.34
Short Term Liquidity
Current Ratio	5.61	2.63	3.74	2.57	7.28
Quick Ratio	5.39	2.43	3.44	2.38	7.11
Operating Cash Flow to Current Liabilities	2.11	-2.05	-1.83	-1.44	1.41
Days Sales Outstanding (Average Receivables)	71.05	36.02	74.46	88.56	11.6
Days Outstanding Inventory (Average Inventory)	268.55	54.19	92.01	76.62	43.9
Average Days Payable Outstanding	187.03	91.27	274.2	-	146.87
Cash Conversion Cycle (Average Days)	152.57	-1.07	-107.73	-	-91.36
Long Term Solvency
Total Debt/Equity	7.77	4.2	7.89	8.09	5.59
Total Debt / Total Capital	7.21	4.03	7.31	7.48	5.3
LT Debt/Equity	7.32	3.69	6.96	7.12	4.83
Long-Term Debt / Total Capital	6.79	3.54	6.45	6.59	4.57
Total Liabilities / Total Assets	52.93	40.56	38.03	34.42	13.23
EBIT / Interest Expense	-6.04	-101.87	-61.06	-	-
EBITDA / Interest Expense	-5.61	-100.57	-55.18	-	-
(EBITDA - Capex) / Interest Expense	-7.25	-112.58	-78.92	-	-
Total Debt / EBITDA	-0.45	-0.03	-0.21	-0.17	0.17
Net Debt / EBITDA	10.24	0.75	2.22	1.45	-1.94
Total Debt / (EBITDA - Capex)	-0.34	-0.02	-0.14	-0.14	0.18
Net Debt / (EBITDA - Capex)	7.92	0.67	1.55	1.2	-2.08
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	180.61	110.74	-34.54	-20.26	895.54
Gross Profit, 1 Yr. Growth %	-434.1	-488.78	-18.46	-31.78	-787.8
EBITDA, 1 Yr. Growth %	25.76	717.01	-79.47	21.76	-189.26
EBITA, 1 Yr. Growth %	25.75	696.55	-78.3	19.96	-181.08
EBIT, 1 Yr. Growth %	27.33	688.58	-78.03	20.06	-178.83
Earnings From Cont. Operations, 1 Yr. Growth %	29.29	218.86	-39.51	4.47	-162.34
Net Income, 1 Yr. Growth %	29.29	218.86	-39.51	4.47	-162.34
Normalized Net Income, 1 Yr. Growth %	45.56	585.87	-78.07	13.92	-188.53
Diluted EPS Before Extra, 1 Yr. Growth %	-5.43	126.61	-40.49	-10.61	-161.02
Accounts Receivable, 1 Yr. Growth %	-89.38	915.59	-51.35	89.78	-1.42
Inventory, 1 Yr. Growth %	134.48	286.48	-57.28	3.38	-97.82
Net Property, Plant and Equip., 1 Yr. Growth %	63.07	99.22	20.61	15.28	-12.19
Total Assets, 1 Yr. Growth %	1.06K	-23.36	-25.71	-8.39	1.85
Tangible Book Value, 1 Yr. Growth %	-1.55K	-3.11	-25.84	-2.57	37.43
Common Equity, 1 Yr. Growth %	-1.76K	-3.22	-22.55	-3.06	34.76
Cash From Operations, 1 Yr. Growth %	-700.72	-240.34	-60.96	-6.39	-138.02
Capital Expenditures, 1 Yr. Growth %	225.18	241.94	-29.14	-40.56	-72.64
Levered Free Cash Flow, 1 Yr. Growth %	-186.96	-1.37K	-47.54	-58.59	-135.48
Unlevered Free Cash Flow, 1 Yr. Growth %	-209.2	-1.11K	-47.38	-58.43	-135.48
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	94.86	143.18	17.45	-27.75	181.74
Gross Profit, 2 Yr. CAGR %	167.03	257.54	62.43	-25.42	116.61
EBITDA, 2 Yr. CAGR %	35.22	226.79	30.49	-50.01	3.99
EBITA, 2 Yr. CAGR %	33.84	216.5	29.22	-48.98	-2.75
EBIT, 2 Yr. CAGR %	34.68	216.88	30.18	-48.64	-3.34
Earnings From Cont. Operations, 2 Yr. CAGR %	34.63	103.04	38.88	-20.51	-19.3
Net Income, 2 Yr. CAGR %	34.63	103.04	38.88	-20.51	-19.3
Normalized Net Income, 2 Yr. CAGR %	46.11	215.97	21.32	-50.01	-0.27
Diluted EPS Before Extra, 2 Yr. CAGR %	15.14	46.39	16.12	-26.98	-26.15
Accounts Receivable, 2 Yr. CAGR %	-48.46	3.86	122.28	-3.91	36.78
Inventory, 2 Yr. CAGR %	121.9	201.04	28.49	-33.55	-84.98
Net Property, Plant and Equip., 2 Yr. CAGR %	57.65	80.24	55.01	17.91	0.61
Total Assets, 2 Yr. CAGR %	246.81	197.78	-24.55	-17.5	-3.41
Tangible Book Value, 2 Yr. CAGR %	417.02	274.48	-15.23	-15	15.71
Common Equity, 2 Yr. CAGR %	370.87	301.06	-13.42	-13.35	14.3
Cash From Operations, 2 Yr. CAGR %	165.5	190.35	-25.99	-39.55	-40.34
Capital Expenditures, 2 Yr. CAGR %	96.53	233.45	55.66	-35.1	-59.67
Levered Free Cash Flow, 2 Yr. CAGR %	-	227.27	155.12	-53.37	-62.06
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	228.04	127.91	-53.23	-61.98
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	100.01	57.02	3.23	73.21
Gross Profit, 3 Yr. CAGR %	-	202.65	105.38	21.64	56.4
EBITDA, 3 Yr. CAGR %	-	146.29	28.96	27.47	-39.8
EBITA, 3 Yr. CAGR %	-	142.54	28.59	26.06	-40.88
EBIT, 3 Yr. CAGR %	-	142.74	29.23	26.72	-41.17
Earnings From Cont. Operations, 3 Yr. CAGR %	-	79.46	35.6	26.3	-26.69
Net Income, 3 Yr. CAGR %	-	79.46	35.6	26.3	-26.69
Normalized Net Income, 3 Yr. CAGR %	-	144.65	28.91	18.8	-39.97
Diluted EPS Before Extra, 3 Yr. CAGR %	-	44.29	8.44	6.5	-31.23
Accounts Receivable, 3 Yr. CAGR %	-	39.22	-19.34	110.87	-3.09
Inventory, 3 Yr. CAGR %	-	166.98	57.02	19.51	-78.72
Net Property, Plant and Equip., 3 Yr. CAGR %	-	70.44	57.65	40.44	6.88
Total Assets, 3 Yr. CAGR %	-	109.67	87.46	-19.51	-11.5
Tangible Book Value, 3 Yr. CAGR %	-	195.87	118.28	-11.21	-0.23
Common Equity, 3 Yr. CAGR %	-	177.89	131.82	-10.09	0.39
Cash From Operations, 3 Yr. CAGR %	-	114.67	48.74	-19.96	-48.21
Capital Expenditures, 3 Yr. CAGR %	-	136.37	98.99	12.93	-51.34
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	76.59	39.05	-57.76
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	77.03	29.25	-57.68
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	33.1	98.39
Gross Profit, 5 Yr. CAGR %	-	-	-	66.55	109.8
EBITDA, 5 Yr. CAGR %	-	-	-	29.56	17.89
EBITA, 5 Yr. CAGR %	-	-	-	29.44	15.15
EBIT, 5 Yr. CAGR %	-	-	-	29.84	14.87
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	29.57	10.18
Net Income, 5 Yr. CAGR %	-	-	-	29.57	10.18
Normalized Net Income, 5 Yr. CAGR %	-	-	-	29.05	16.14
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	9.88	-6.96
Accounts Receivable, 5 Yr. CAGR %	-	-	-	20.03	-0.37
Inventory, 5 Yr. CAGR %	-	-	-	53.07	-38.6
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	47.09	31.73
Total Assets, 5 Yr. CAGR %	-	-	-	44.38	43.79
Tangible Book Value, 5 Yr. CAGR %	-	-	-	79.65	69.34
Common Equity, 5 Yr. CAGR %	-	-	-	74.35	74.7
Cash From Operations, 5 Yr. CAGR %	-	-	-	29.3	3.21
Capital Expenditures, 5 Yr. CAGR %	-	-	-	40.95	5.08
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	-4.65
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	-4.38